On May 20, 2022, Cinclus Pharma Holding AB closed the transaction. The transaction was oversubscribed and included participation from number of swedish and international institutional investors, including certain existing shareholders, participated in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68.6 SEK | +0.15% | +5.54% | +6.19% |
Apr. 22 | Linc AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Jan. 25 | Linc AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+6.19% | 362M | |
-11.83% | 150M | |
+1.78% | 141M |
- Stock Market
- Equities
- LINC Stock
- News Linc AB
- Cinclus Pharma Holding AB announced that it has received SEK 240 million in funding from Trill Impact AB, Eir Ventures, Irrus Investments Nominee Limited, AP Fonden 4, Linc AB